{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:07:50Z","timestamp":1790024870174,"version":"4.0.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T00:00:00Z","timestamp":1567468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s11481-019-09876-9","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T10:08:41Z","timestamp":1567505321000},"page":"17-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The Role of \u03b2-Blockers in Melanoma"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6531-7998","authenticated-orcid":false,"given":"Vincenzo","family":"De Giorgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3797-8371","authenticated-orcid":false,"given":"Pierangelo","family":"Geppetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9592-2873","authenticated-orcid":false,"given":"Chiara","family":"Lupi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6316-430X","authenticated-orcid":false,"given":"Silvia","family":"Benemei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"9876_CR1","first-page":"399","volume":"12","author":"GH Algire","year":"1951","unstructured":"Algire GH, Legallais FY (1951) Vascular reactions of Normal and malignant tissue in vivo. IV The effect of peripheral hypotension on transplanted tumors. J Natl Cancer Inst 12:399\u2013421","journal-title":"J Natl Cancer Inst"},{"key":"9876_CR2","first-page":"159","volume-title":"The biology of melanomas","author":"GH Algire","year":"1958","unstructured":"Algire GH, Legallais FY (1958) Growth and vascularization of transplanted mouse melanoma. In: The biology of melanomas. Academic Press, Inc, New York, pp 159\u2013170"},{"key":"9876_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/sj.bjp.0706048","volume":"144","author":"JG Baker","year":"2005","unstructured":"Baker JG (2005) The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors. Br J Pharmacol 144:317\u2013322","journal-title":"Br J Pharmacol"},{"key":"9876_CR4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1567201811310010011","volume":"10","author":"JL Balligand","year":"2013","unstructured":"Balligand JL (2013) Beta3-adrenoreceptors in cardiovascular diseases: new roles for an \"old\" receptor. Curr Drug Deliv 10:64\u201366","journal-title":"Curr Drug Deliv"},{"key":"9876_CR5","unstructured":"Bond RA, Bylund DB, Eikenburg DC, Hieble JP, Hills R, Minneman KP, Parra S (2019) Adrenoceptors: \u03b23-adrenoceptor. Last modified on 27\/02\/2019. IUPHAR\/BPS Guide Pharmacol. \nhttp:\/\/www.guidetopharmacology.org\/GRAC\/ObjectDisplayForward?objectId=30\n\n. Accessed 17 Apr 2019"},{"key":"9876_CR6","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-17-0546","volume":"77","author":"MJ Bucsek","year":"2017","unstructured":"Bucsek MJ, Qiao G, MacDonald CR, Giridharan T, Evans L, Niedzwecki B, Liu H, Kokolus KM, Eng JW, Messmer MN, Attwood K, Abrams SI, Hylander BL, Repasky EA (2017) \u03b2-adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8+ T cells and undermines checkpoint inhibitor therapy. Cancer Res 77:5639\u20135651","journal-title":"Cancer Res"},{"key":"9876_CR7","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.18632\/oncotarget.2652","volume":"6","author":"M Calvani","year":"2015","unstructured":"Calvani M, Pelon F, Comito G, Taddei ML, Moretti S, Innocenti S, Nassini R, Gerlini G, Borgognoni L, Bambi F, Giannoni E, Filippi L, Chiarugi P (2015) Norepinephrine promotes tumor microenvironment reactivity through \u03b23-adrenoceptors during melanoma progression. Oncotarget 6:4615\u20134632","journal-title":"Oncotarget"},{"key":"9876_CR8","doi-asserted-by":"crossref","first-page":"6816508","DOI":"10.1155\/2018\/6816508","volume":"2018","author":"M Calvani","year":"2018","unstructured":"Calvani M, Cavallini L, Tondo A, Spinelli V, Ricci L, Pasha A, Bruno G, Buonvicino D, Bigagli E, Vignoli M, Bianchini F, Sartiani L, Lodovici M, Semeraro R, Fontani F, De Logu F, Dal Monte M, Chiarugi P, Favre C, Filippi L (2018) \u03b23-Adrenoreceptors control mitochondrial dormancy in melanoma and embryonic stem cells. Oxidative Med Cell Longev 2018:6816508","journal-title":"Oxidative Med Cell Longev"},{"key":"9876_CR9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jdv.14566","volume":"32","author":"L Chen","year":"2017","unstructured":"Chen L, Tsai TF (2017) The role of \u03b2-blockers in dermatological treatment: a review. J Eur Acad Dermatol Venereol 32:363\u2013371","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9876_CR10","first-page":"490","volume":"45","author":"P Chidiac","year":"1994","unstructured":"Chidiac P, Hebert TE, Valiquette M, Dennis M, Bouvier M (1994) Inverse agonist activity of beta-adrenergic antagonists. Mol Pharmacol 45:490\u2013499","journal-title":"Mol Pharmacol"},{"key":"9876_CR11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/mc.22820","volume":"57","author":"KH Cleveland","year":"2018","unstructured":"Cleveland KH, Yeung S, Huang KM, Liang S, Andresen BT, Huang Y (2018) Phosphoproteome profiling provides insight into the mechanism of action for carvedilol-mediated cancer prevention. Mol Carcinog 57:997\u20131007","journal-title":"Mol Carcinog"},{"key":"9876_CR12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00432-016-2278-1","volume":"143","author":"M Coelho","year":"2017","unstructured":"Coelho M, Soares-Silva C, Brand\u00e3o D, Marino F, Cosentino M, Ribeiro L (2017) \u03b2-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives. J Cancer Res Clin Oncol 143:275\u2013291","journal-title":"J Cancer Res Clin Oncol"},{"key":"9876_CR13","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00109-013-1073-6","volume":"91","author":"M Dal Monte","year":"2013","unstructured":"Dal Monte M, Casini G, Filippi L, Nicchia GP, Svelto M, Bagnoli P (2013) Functional involvement of \u03b23-adrenergic receptors in melanoma growth and vascularization. J Mol Med 91:1407\u20131419","journal-title":"J Mol Med"},{"key":"9876_CR14","first-page":"779","volume":"171","author":"V De Giorgi","year":"2011","unstructured":"De Giorgi V, Grazzini M, Gandini S, Benemei S, Lotti T, Marchionni N, Geppetti P (2011) Treatment with \u03b2-blockers and reduced disease progression in patients with thick melanoma. Arch Intern Med 171:779\u2013781","journal-title":"Arch Intern Med"},{"key":"9876_CR15","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.mayocp.2013.09.001","volume":"88","author":"V De Giorgi","year":"2013","unstructured":"De Giorgi V, Gandini S, Grazzini M, Benemei S, Marchionni N, Geppetti P (2013) Effect of \u03b2-blockers and other antihypertensive drugs on the risk of melanoma recurrence and death. Mayo Clin Proc 88:1196\u20131203","journal-title":"Mayo Clin Proc"},{"key":"9876_CR16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/CMR.0000000000000317","volume":"27","author":"V De Giorgi","year":"2017","unstructured":"De Giorgi V, Grazzini M, Benemei S, Marchionni N, Geppetti P, Gandini S (2017) \u03b2-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-up. Melanoma Res 27:268\u2013270","journal-title":"Melanoma Res"},{"issue":"2","key":"9876_CR17","doi-asserted-by":"crossref","first-page":"e172908","DOI":"10.1001\/jamaoncol.2017.2908","volume":"4","author":"V De Giorgi","year":"2018","unstructured":"De Giorgi V, Grazzini M, Benemei S, Marchionni N, Botteri E, Pennacchioli E, Geppetti P, Gandini S (2018) Propranolol for off-label treatment of patients with melanoma: results from a cohort study. JAMA Oncol 4(2):e172908","journal-title":"JAMA Oncol"},{"key":"9876_CR18","first-page":"1420","volume":"26","author":"RF Edlich","year":"1966","unstructured":"Edlich RF, Rogers W, DeShazo CV Jr, Aust JB (1966) Effect of vasoactive drugs on tissue blood flow in the hamster melanoma. Cancer Res 26:1420\u20131424","journal-title":"Cancer Res"},{"key":"9876_CR19","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/CMR.0000000000000299","volume":"26","author":"JJ Failing","year":"2016","unstructured":"Failing JJ, Finnes HD, Kottschade LA, Allred JB, Markovic SN (2016) Effects of commonly used chronic medications on the outcomes of ipilimumab therapy in patients with metastatic melanoma. Melanoma Res 26:609\u2013615","journal-title":"Melanoma Res"},{"key":"9876_CR20","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.4049\/jimmunol.0903301","volume":"184","author":"A Glasner","year":"2010","unstructured":"Glasner A, Avraham R, Rosenne E, Bensih M, Zmora O, Shemer S, Meiboom H, Ben-Eliyahu S (2010) Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol 184:2449\u20132457","journal-title":"J Immunol"},{"key":"9876_CR21","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/SLA.0b013e318211d7b5","volume":"253","author":"Y Goldfarb","year":"2011","unstructured":"Goldfarb Y, Sorski L, Benish M, Levi B, Melamed R, Ben-Eliyahu S (2011) Improving postoperative immune status and resistance to cancer metastasis: a combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg 253:798\u2013810","journal-title":"Ann Surg"},{"key":"9876_CR22","first-page":"69","volume":"37","author":"DS Goldstein","year":"2003","unstructured":"Goldstein DS (2003) Catecholamines and stress. Endocr Regul 37:69\u201380","journal-title":"Endocr Regul"},{"key":"9876_CR23","first-page":"1465","volume":"27","author":"PM Guillino","year":"1961","unstructured":"Guillino PM, Grantham FH (1961) Studies on the exchange of fluid between host and tumor. II. The blood flow of hepatomas and other tumors in rats and mice. J Natl Cancer Inst 27:1465\u20131491","journal-title":"J Natl Cancer Inst"},{"key":"9876_CR24","first-page":"211","volume":"28","author":"PM Guillino","year":"1962","unstructured":"Guillino PM, Grantham FH (1962) Studies on the exchange of fluid between host and tumor. III. Regulation of blood flow in hepatomas and other rat tumors. J Natl Cancer Inst 28:211\u2013230","journal-title":"J Natl Cancer Inst"},{"key":"9876_CR25","volume":"8","author":"S Hassan","year":"2013","unstructured":"Hassan S, Karpova Y, Flores A, D'Agostino R Jr, Kulik G (2013) Surgical stress delays prostate involution in mice. PLoS One 8:e78175","journal-title":"PLoS One"},{"key":"9876_CR26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00540-016-2171-8","volume":"30","author":"K Hirota","year":"2016","unstructured":"Hirota K (2016) Adrenoceptor modulators and cancer progression. J Anesth 30:365\u2013368","journal-title":"J Anesth"},{"key":"9876_CR27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.puhe.2017.04.026","volume":"149","author":"Y Jia","year":"2017","unstructured":"Jia Y, Li F, Liu YF, Zhao JP, Leng MM, Chen L (2017) Depression and cancer risk: a systematic review and meta-analysis. Public Health 149:138\u2013148","journal-title":"Public Health"},{"key":"9876_CR28","volume-title":"Introduction to autonomic pharmacology in basic & clinical pharmacology","author":"BG Katzung","year":"2012","unstructured":"Katzung BG (2012) Introduction to autonomic pharmacology in basic & clinical pharmacology, 12th edn. The McGraw-Hill, New York","edition":"12"},{"key":"9876_CR29","volume":"7","author":"KM Kokolus","year":"2017","unstructured":"Kokolus KM, Zhang Y, Sivik JM, Schmeck C, Zhu J, Repasky EA, Drabick JJ, Schell TD (2017) Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice. Oncoimmunology 7:e1405205","journal-title":"Oncoimmunology"},{"key":"9876_CR30","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/10253890.2016.1203415","volume":"9","author":"O Krizanova","year":"2016","unstructured":"Krizanova O, Babula P, Pacak K (2016) Stress, catecholaminergic system and cancer. Stress 9:419\u2013428","journal-title":"Stress"},{"key":"9876_CR31","doi-asserted-by":"crossref","first-page":"802","DOI":"10.18632\/oncotarget.22696","volume":"9","author":"X Kuang","year":"2017","unstructured":"Kuang X, Qi M, Peng C, Zhou C, Su J, Zeng W, Liu H, Zhang J, Chen M, Shen M, Xie X, Li F, Zhao S, Li Q, Luo Z, Chen J, Tao J, He Y, Chen X (2017) Propranolol enhanced the anti-tumor effect of sunitinib by inhibiting proliferation and inducing G0\/G1\/S phase arrest in malignant melanoma. Oncotarget 9:802\u2013811","journal-title":"Oncotarget"},{"key":"9876_CR32","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","volume":"358","author":"C Leaute-Labreze","year":"2008","unstructured":"Leaute-Labreze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Ta\u00efeb A (2008) Propranolol for severe hemangiomas of infancy. N Engl J Med 358:2649\u20132651","journal-title":"N Engl J Med"},{"key":"9876_CR33","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1055-9965.EPI-11-0249","volume":"20","author":"S Lameshow","year":"2011","unstructured":"Lameshow S, S\u00f8rensen HT, Phillips G, Yang EV, Antonsen S, Riis AH, Lesinski GB, Jackson R, Glaser R (2011) \u03b2-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study. Cancer Epidemiol Biomark Prev 20:2273\u20132279","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"9876_CR34","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.ejca.2013.07.141","volume":"49","author":"E Livingstone","year":"2013","unstructured":"Livingstone E, Hollestein LM, van Herk-Sukel MP, van de Poll-Franse L, Nijsten T, Schadendorf D, de Vries E (2013) \u03b2-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study. Eur J Cancer 49:3863\u20133871","journal-title":"Eur J Cancer"},{"key":"9876_CR35","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.ehj.2004.06.002","volume":"25","author":"J L\u00f3pez-Send\u00f3n","year":"2004","unstructured":"L\u00f3pez-Send\u00f3n J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C, Task force on Beta-blockers of the European Society of Cardiology (2004) Expert consensus document on beta-adrenergic receptor blockers. Eur Heart J 25:1341\u20131362","journal-title":"Eur Heart J"},{"issue":"2","key":"9876_CR36","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/bph.13662","volume":"174","author":"S Maccari","year":"2017","unstructured":"Maccari S, Buoncervello M, Rampin A, Spada M, Macchia D, Giordani L, Stati T, Bearzi C, Catalano L, Rizzi R, Gabriele L, Marano G (2017) Biphasic effects of propranolol on tumour growth in B16F10 melanoma-bearing mice. Br J Pharmacol 174(2):139\u2013149","journal-title":"Br J Pharmacol"},{"key":"9876_CR37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00726-011-1186-6","volume":"45","author":"F Marino","year":"2013","unstructured":"Marino F, Cosentino M (2013) Adrenergic modulation of immune cells: an update. Amino Acids 45:55\u201371","journal-title":"Amino Acids"},{"key":"9876_CR38","doi-asserted-by":"crossref","first-page":"516","DOI":"10.2340\/00015555-2035","volume":"95","author":"E Maverakis","year":"2015","unstructured":"Maverakis E, Cornelius LA, Bowen GM, Phan T, Patel FB, Fitzmaurice S, He Y, Burrall B, Duong C, Kloxin AM, Sultani H, Wilken R, Martinez SR, Patel F (2015) Metastatic melanoma\u2014a review of current and future treatment options. Acta Derm Venereol 95:516\u2013524","journal-title":"Acta Derm Venereol"},{"key":"9876_CR39","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/bjd.12894","volume":"170","author":"C McCourt","year":"2014","unstructured":"McCourt C, Coleman HG, Murray LJ, Cantwell MM, Dolan O, Powe DG, Cardwell CR (2014) Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case\u2013control study. Br J Dermatol 170:930\u2013938","journal-title":"Br J Dermatol"},{"key":"9876_CR40","doi-asserted-by":"crossref","first-page":"70936","DOI":"10.18632\/oncotarget.12342","volume":"7","author":"HY Min","year":"2016","unstructured":"Min HY, Boo HJ, Lee HJ, Jang HJ, Yun HJ, Hwang SJ, Smith JK, Lee HJ, Lee HY (2016) Smoking-associated lung cancer prevention by blockade of the beta-adrenergic receptor-mediated insulin-like growth factor receptor activation. Oncotarget 7:70936\u201370947","journal-title":"Oncotarget"},{"key":"9876_CR41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/labinvest.2012.175","volume":"93","author":"S Moretti","year":"2013","unstructured":"Moretti S, Massi D, Farini V, Baroni G, Parri M, Innocenti S, Cecchi R, Chiarugi P (2013) \u03b2-Adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines. Lab Investig 93:279\u2013290","journal-title":"Lab Investig"},{"key":"9876_CR42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5966\/sctm.2015-0076","volume":"5","author":"NC Munabi","year":"2016","unstructured":"Munabi NC, England RW, Edwards AK, Kitajewski AA, Tan QK, Weinstein A, Kung JE, Wilcox M, Kitajewski JK, Shawber CJ, Wu JK (2016) Propranolol targets hemangioma stem cells via cAMP and mitogen-activated protein kinase regulation. Stem Cells Transl Med 5:45\u201355","journal-title":"Stem Cells Transl Med"},{"key":"9876_CR43","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.2147\/OTT.S167422","volume":"11","author":"Z Na","year":"2018","unstructured":"Na Z, Qiao X, Hao X, Fan L, Xiao Y, Shao Y, Sun M, Feng Z, Guo W, Li J, Li J, Li D (2018) The effects of beta-blocker use on cancer prognosis: a meta-analysis based on 319,006 patients. Onco Targets Ther 11:4913\u20134944","journal-title":"Onco Targets Ther"},{"key":"9876_CR44","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1038\/bjc.2013.205","volume":"108","author":"E Pasquier","year":"2013","unstructured":"Pasquier E, Street J, Pouchy C, Carre M, Gifford AJ, Murray J, Norris MD, Trahair T, Andre N, Kavallaris M (2013) \u03b2-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma. Br J Cancer 108:2485\u20132494","journal-title":"Br J Cancer"},{"key":"9876_CR45","doi-asserted-by":"crossref","first-page":"95","DOI":"10.18632\/oncoscience.357","volume":"4","author":"SL Rains","year":"2017","unstructured":"Rains SL, Amaya CN, Bryan BA (2017) Beta-adrenergic receptors are expressed across diverse cancers. Oncoscience 4:95\u2013105","journal-title":"Oncoscience"},{"key":"9876_CR46","doi-asserted-by":"crossref","first-page":"483493","DOI":"10.1155\/2010\/483493","volume":"2010","author":"M Sanzo","year":"2010","unstructured":"Sanzo M, Colucci R, Arunachalam M, Berti S, Moretti S (2010) Stress as a possible mechanism in melanoma progression. Dermatol Res Pract 2010:483493","journal-title":"Dermatol Res Pract"},{"key":"9876_CR47","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/carcin\/10.9.1753","volume":"10","author":"HM Schuller","year":"1989","unstructured":"Schuller HM, Cole B (1989) Regulation of cell proliferation by beta-adrenergic receptors in a human lung adenocarcinoma cell line. Carcinogenesis 10:1753\u20131755","journal-title":"Carcinogenesis"},{"key":"9876_CR48","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00210-015-1165-7","volume":"388","author":"F Sereni","year":"2015","unstructured":"Sereni F, Dal Monte M, Filippi L, Bagnoli P (2015) Role of host \u03b21- and \u03b22-adrenergic receptors in a murine model of B16 melanoma: functional involvement of \u03b23-adrenergic receptors. Naunyn Schmiedeberg's Arch Pharmacol 388:1317\u20131331","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"9876_CR49","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/1097-0142(19940815)74:4+<1453::AID-CNCR2820741609>3.0.CO;2-1","volume":"74","author":"D Spiegel","year":"1994","unstructured":"Spiegel D (1994) Health caring. Psychosocial support for patients with cancer. Cancer 74:1453\u20131457","journal-title":"Cancer"},{"key":"9876_CR50","first-page":"387","volume":"24","author":"TP Stanojkovic","year":"2005","unstructured":"Stanojkovic TP, Zizak Z, Mihailovic-Stanojevic N, Petrovic T, Juranic Z (2005) Inhibition of proliferation on some neoplastic cell lines-act of carvedilol and captopril. Exp Clin Cancer Res 24:387\u2013395","journal-title":"Exp Clin Cancer Res"},{"key":"9876_CR51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2133.1990.tb01843.x","volume":"123","author":"V Steinkraus","year":"1990","unstructured":"Steinkraus V, Nose M, Mensing H, K\u00f6rner C (1990) Radioligand binding characteristics of beta 2-adrenoceptors of cultured melanoma cells. Br J Dermatol 123:163\u2013170","journal-title":"Br J Dermatol"},{"key":"9876_CR52","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.semcancer.2013.08.009","volume":"23","author":"J Tang","year":"2013","unstructured":"Tang J, Li Z, Lu L, Cho CH (2013) \u03b2-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy. Semin Cancer Biol 23:533\u2013542","journal-title":"Semin Cancer Biol"},{"key":"9876_CR53","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm1447","volume":"12","author":"PH Thaker","year":"2006","unstructured":"Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M, Merritt WM, Lin YG, Mangala LS, Kim TJ, Coleman RL, Landen CN, Li Y, Felix E, Sanguino AM, Newman RA, Lloyd M, Gershenson DM, Kundra V, Lopez-Berestein G, Lutgendorf SK, Cole SW, Sood AK (2006) Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12:939\u2013944","journal-title":"Nat Med"},{"key":"9876_CR54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/1479-5876-11-72","volume":"11","author":"SL Valles","year":"2013","unstructured":"Valles SL, Benlloch M, Rodriguez ML, Mena S, Pellicer JA, Asensi M, Obrador E, Estrela JM (2013) Stress hormones promote growth of B16-F10 melanoma metastases: an interleukin 6- and glutathione-dependent mechanism. J Transl Med 11:72","journal-title":"J Transl Med"},{"key":"9876_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2016.04.004","volume":"47","author":"J Weberpals","year":"2016","unstructured":"Weberpals J, Jansen L, Carr PR, Hoffmeister M, Brenner H (2016) Beta blockers and cancer prognosis - the role of immortal time bias: a systematic review and meta-analysis. Cancer Treat Rev 47:1\u201311","journal-title":"Cancer Treat Rev"},{"key":"9876_CR56","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"TC Westfall","year":"2011","unstructured":"Westfall TC, Westfall DP (2011) Adrenergic agonists and antagonists. In: Brunton LL (ed) Goodman & Gilman\u2019s the pharmacological basis of therapeutics, 12th edn. The McGraw-Hill, New York","edition":"12"},{"key":"9876_CR57","unstructured":"WHO-Skin Cancer (2019) \nhttps:\/\/www.who.int\/uv\/faq\/skincancer\/en\/index1.html\n\n. Accessed 11 Apr 2019"},{"key":"9876_CR58","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.cellsig.2015.02.012","volume":"27","author":"A Wnorowski","year":"2015","unstructured":"Wnorowski A, Sadowska M, Paul RK, Singh NS, Boguszewska-Czubara A, Jimenez L, Abdelmohsen K, Toll L, Jozwiak K, Bernier M, Wainer IW (2015) Activation of \u03b22-adrenergic receptor by (R,R')-4\u2032-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells. Cell Signal 27:997\u20131007","journal-title":"Cell Signal"},{"key":"9876_CR59","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/jid.2014.373","volume":"135","author":"LJ Wrobel","year":"2015","unstructured":"Wrobel LJ, Le Gal FA (2015) Inhibition of human melanoma growth by a non-cardioselective \u03b2-blocker. Invest Dermatol 135:525\u2013531","journal-title":"Invest Dermatol"},{"key":"9876_CR60","doi-asserted-by":"crossref","first-page":"77825","DOI":"10.18632\/oncotarget.12833","volume":"7","author":"LJ Wrobel","year":"2016","unstructured":"Wrobel LJ, Bod L, Lengagne R, Kato M, Pr\u00e9vost-Blondel A, Le Gal FA (2016) Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma. Oncotarget 7:77825\u201377837","journal-title":"Oncotarget"},{"key":"9876_CR61","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbi.2008.10.005","volume":"23","author":"EV Yang","year":"2009","unstructured":"Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, Barsky SH, Glaser R (2009) Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 23:267\u2013275","journal-title":"Brain Behav Immun"},{"key":"9876_CR62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bja.2018.03.024","volume":"21","author":"A Yap","year":"2018","unstructured":"Yap A, Lopez-Olivo MA, Dubowitz J, Pratt G, Hiller J, Gottumukkala V, Sloan E, Riedel B, Schier R (2018) Effect of beta-blockers on cancer recurrence and survival: a meta-analysis of epidemiological and perioperative studies. Br J Anaesth 21:45\u201357","journal-title":"Br J Anaesth"},{"key":"9876_CR63","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1126\/science.aah5072","volume":"358","author":"AH Zahalka","year":"2017","unstructured":"Zahalka AH, Arnal-Estap\u00e9 A, Maryanovich M, Nakahara F, Cruz CD, Finley LWS, Frenette PS (2017) Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science 358:321\u2013326","journal-title":"Science"},{"key":"9876_CR64","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4161\/cbt.10.1.11944","volume":"10","author":"D Zhang","year":"2010","unstructured":"Zhang D, Ma QY, Hu HT, Zhang M (2010) \u03b22-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NF\u03baB and AP-1. Cancer Biol Ther 10:19\u201329","journal-title":"Cancer Biol Ther"},{"key":"9876_CR65","doi-asserted-by":"crossref","first-page":"68314","DOI":"10.18632\/oncotarget.11599","volume":"7","author":"C Zhou","year":"2016","unstructured":"Zhou C, Chen X, Zeng W, Peng C, Huang G, Li X, Ouyang Z, Luo Y, Xu X, Xu B, Wang W, He R, Zhang X, Zhang L, Liu J, Knepper TC, He Y, McLeod HL (2016) Propranolol induced G0\/G1\/S phase arrest and apoptosis in melanoma cells via AKT\/MAPK pathway. Oncotarget 7:68314\u201368327","journal-title":"Oncotarget"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-019-09876-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-019-09876-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-019-09876-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:41:04Z","timestamp":1599003664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-019-09876-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["9876"],"URL":"https:\/\/doi.org\/10.1007\/s11481-019-09876-9","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]},"assertion":[{"value":"1 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}